Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Etoposide | 10 | uM | 3 | 156.25 | 80.34 | 74.00 | 74.50 | 0.9933 | 1.1275 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 3 | 156.25 | 80.34 | 106.00 | 74.50 | 1.4228 | -0.9214 |
| SK-BR-3 | PLX-4720 | 0.01 | uM | 3 | 156.25 | 80.34 | 105.00 | 74.50 | 1.4094 | -0.9143 |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 63.00 | 74.50 | 0.8456 | 8.3196 | |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 82.00 | 74.50 | 1.1007 | -0.1708 | |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 241.00 | 469.25 | 0.5136 | -0.0729 | |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 387.00 | 469.25 | 0.8247 | 0.6013 | |
| SK-BR-3 | Etoposide | 19.9526 | uM | 3 | 312.50 | 257.33 | 274.00 | 469.25 | 0.5839 | 0.0751 |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 574.00 | 469.25 | 1.2232 | 1.5234 | |
| SK-BR-3 | Nilotinib | 0.1 | uM | 3 | 312.50 | 257.33 | 532.00 | 469.25 | 1.1337 | 1.3116 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 3 | 312.50 | 257.33 | 492.00 | 469.25 | 1.0485 | 1.1123 |
| SK-BR-3 | Nilotinib | 10 | uM | 3 | 312.50 | 257.33 | 907.00 | 469.25 | 1.9329 | 3.2780 |
| SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 3 | 312.50 | 257.33 | 283.00 | 469.25 | 0.6031 | 0.1159 |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 3 | 312.50 | 257.33 | 181.00 | 469.25 | 0.3857 | -0.3337 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 3 | 312.50 | 257.33 | 515.00 | 469.25 | 1.0975 | 1.2266 |
| SK-BR-3 | PLX-4720 | 1 | uM | 3 | 312.50 | 257.33 | 443.00 | 469.25 | 0.9441 | 0.8715 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 3 | 312.50 | 257.33 | 1010.00 | 469.25 | 2.1524 | 3.8433 |
| SK-BR-3 | Nilotinib | 1 | uM | 3 | 312.50 | 257.33 | 458.00 | 469.25 | 0.9760 | 0.9448 |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 671.00 | 469.25 | 1.4299 | 2.0216 | |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 3 | 312.50 | 257.33 | 355.00 | 469.25 | 0.7565 | 0.4495 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 3 | 312.50 | 257.33 | 457.00 | 469.25 | 0.9739 | 0.9399 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 3 | 312.50 | 257.33 | 517.00 | 469.25 | 1.1018 | 1.2366 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 3 | 312.50 | 257.33 | 268.00 | 469.25 | 0.5711 | 0.0480 |
| SK-BR-3 | Etoposide | 0.31623 | uM | 3 | 312.50 | 257.33 | 236.00 | 469.25 | 0.5029 | -0.0950 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 3 | 312.50 | 257.33 | 454.00 | 469.25 | 0.9675 | 0.9252 |